CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Charles River Laboratories International, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2010 to Q2 2024.
  • Charles River Laboratories International, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 29, 2024 was 51.8M shares, a 0.74% increase year-over-year.
  • Charles River Laboratories International, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 51.5M shares, a 0.29% increase from 2022.
  • Charles River Laboratories International, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 51.3M shares, a 0.24% decline from 2021.
  • Charles River Laboratories International, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 51.4M shares, a 1.61% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 51.8M +379K +0.74% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-07
Q1 2024 51.8M +414K +0.81% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-09
Q4 2023 51.5M +150K +0.29% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-14
Q3 2023 51.6M +324K +0.63% Jul 2, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 51.5M +184K +0.36% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-07
Q1 2023 51.4M +103K +0.2% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q4 2022 51.3M -124K -0.24% Sep 25, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 51.3M -275K -0.53% Jun 26, 2022 Sep 24, 2022 10-Q 2023-11-08
Q2 2022 51.3M -51K -0.1% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-09
Q1 2022 51.3M +250K +0.49% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q4 2021 51.4M +814K +1.61% Sep 26, 2021 Dec 25, 2021 10-K 2024-02-14
Q3 2021 51.6M +856K +1.69% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-02
Q2 2021 51.3M +1.09M +2.17% Mar 28, 2021 Jun 26, 2021 10-Q 2022-08-03
Q1 2021 51.1M +1.11M +2.22% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q4 2020 50.6M +918K +1.85% Sep 27, 2020 Dec 26, 2020 10-K 2023-02-22
Q3 2020 50.7M +987K +1.99% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-03
Q2 2020 50.2M +584K +1.18% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-04
Q1 2020 50M +504K +1.02% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q4 2019 49.7M +675K +1.38% Sep 29, 2019 Dec 28, 2019 10-K 2022-02-16
Q3 2019 49.7M +389K +0.79% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-09
Q2 2019 49.7M +619K +1.26% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-05
Q1 2019 49.5M +634K +1.3% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-07
Q4 2018 49M +454K +0.94% Sep 30, 2018 Dec 29, 2018 10-K 2021-02-17
Q3 2018 49.3M +936K +1.93% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-06
Q2 2018 49M +701K +1.45% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 48.8M +407K +0.84% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 48.6M +606K +1.26% Oct 1, 2017 Dec 30, 2017 10-K 2020-02-11
Q3 2017 48.4M +356K +0.74% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 48.3M +423K +0.88% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-08
Q1 2017 48.4M +804K +1.69% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-10
Q4 2016 48M +324K +0.68% Sep 25, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 48M +789K +1.67% Jun 26, 2016 Sep 24, 2016 10-Q 2017-11-09
Q2 2016 47.9M +369K +0.78% Mar 27, 2016 Jun 25, 2016 10-Q 2017-08-09
Q1 2016 47.6M -251K -0.52% Dec 27, 2015 Mar 26, 2016 10-Q 2017-05-10
Q4 2015 47.6M +76K +0.16% Sep 27, 2015 Dec 26, 2015 10-K 2018-02-13
Q3 2015 47.2M +367K +0.78% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-02
Q2 2015 47.6M -134K -0.28% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-03
Q1 2015 47.9M -283K -0.59% Dec 28, 2014 Mar 28, 2015 10-Q 2016-05-04
Q4 2014 47.6M -931K -1.92% Sep 28, 2014 Dec 27, 2014 10-K 2017-02-14
Q3 2014 46.9M -1.56M -3.23% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 47.7M -1.15M -2.36% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 48.2M -285K -0.59% Dec 29, 2013 Mar 29, 2014 10-Q 2015-04-30
Q4 2013 48.5M +83K +0.17% Sep 29, 2013 Dec 28, 2013 10-K 2014-02-25
Q3 2013 48.4M +333K +0.69% Jun 30, 2013 Sep 28, 2013 10-Q 2014-10-30
Q2 2013 48.8M +423K +0.87% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-07
Q1 2013 48.4M -336K -0.69% Dec 30, 2012 Mar 30, 2013 10-Q 2014-04-30
Q4 2012 48.4M -2.91M -5.67% Sep 30, 2012 Dec 29, 2012 10-K 2014-02-25
Q3 2012 48.1M -2.43M -4.8% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 48.4M -3.27M -6.32% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 48.8M -5.83M -10.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 51.3M Sep 25, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 50.5M -12.1M -19.3% Jun 26, 2011 Sep 24, 2011 10-Q 2012-11-01
Q2 2011 51.7M -14.2M -21.5% Mar 27, 2011 Jun 25, 2011 10-Q 2012-08-07
Q1 2011 54.6M Dec 26, 2010 Mar 26, 2011 10-Q 2012-05-04
Q3 2010 62.6M Jun 27, 2010 Sep 25, 2010 10-Q 2011-11-02
Q2 2010 65.9M Mar 28, 2010 Jun 26, 2010 10-Q 2011-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.